Cite
HARVARD Citation
Picchianti Diamanti, A. et al. (n.d.). Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents. Clinical and experimental immunology. pp. 630-640. [Online].